RECRUITINGNA

Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors

This project aims to adapt, implement, and evaluate PLA based intervention in urban Karachi, Pakistan for TIIDM prevention and control.

Sponsor

Baqai Institute of Diabetology and Endocrinology

Enrollment

240 participants

Sites

1 locations

Start Date

June 2024

Completion

November 2026

Type II Diabetes MellitusParticipatory, learning and Action (PLA) Based intervention

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

240

participants

Sites

locations

Duration

3.3 years

total trial span

Rate

pts/month needed

Jun 2024Month 26 of 40Nov 2026

65% of trial timeline elapsed14 months to primary endpoint

At 1 sites, each site needs to enroll approximately 6.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Prevalence of Type II Diabetes Mellitus

18 months

HbA1c biochemical test

Two-year cumulative incidence of Type II Diabetes Mellitus

18 months

HbA1c biochemical test

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Engagement of coMmunity through Participatory learning and action for cOntrol and preVEntion of Type 2 Diabetes and its Risk factors (EMPOWER-D): protocol for a feasibility cluster randomised controlled trial in urban Pakistan.

Imtiaz Sara, Zafar Rubia, Tahir Amber et al.Pilot and feasibility studies2026

DOI PubMed

Engaging communities through participatory learning action for the control and prevention of diabetes: A protocol for the Process Evaluation of the EMPOWER-D trial in Pakistan and Afghanistan.

Khattak Maria Ishaq, Rehman Khalid, Afaq Saima et al.PloS one2026

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

RECRUITINGNA

Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors

This project aims to adapt, implement, and evaluate PLA based intervention in urban Karachi, Pakistan for TIIDM prevention and control.

Sponsor

Baqai Institute of Diabetology and Endocrinology

Enrollment

240 participants

Sites

1 locations

Start Date

June 2024

Completion

November 2026

Type II Diabetes MellitusParticipatory, learning and Action (PLA) Based intervention

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

240

participants

Sites

locations

Duration

3.3 years

total trial span

Rate

pts/month needed

Jun 2024Month 26 of 40Nov 2026

65% of trial timeline elapsed14 months to primary endpoint

At 1 sites, each site needs to enroll approximately 6.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Prevalence of Type II Diabetes Mellitus

18 months

HbA1c biochemical test

Two-year cumulative incidence of Type II Diabetes Mellitus

18 months

HbA1c biochemical test

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Imtiaz Sara, Zafar Rubia, Tahir Amber et al.Pilot and feasibility studies2026

DOI PubMed

Engaging communities through participatory learning action for the control and prevention of diabetes: A protocol for the Process Evaluation of the EMPOWER-D trial in Pakistan and Afghanistan.

Khattak Maria Ishaq, Rehman Khalid, Afaq Saima et al.PloS one2026

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Eligibility

Min Age

20 Years

Sex

all

Healthy Volunteers

Yes

View full criteria

Inclusion Criteria:

* Individuals aged 20 years and above.
* Participants residing in the randomized clusters of Karachi, Pakistan
* Individuals willing to participate in the study and provide consent.
* Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate.
* Participants who can attend the scheduled meetings and interventions as per the study protocol.

Exclusion Criteria:

* Individuals below the age of 20 years.
* Individuals unwilling to provide consent for participation.
* Participants with severe health conditions that may hinder their active involvement in the study.
* Individuals with non-compliance with research protocols

Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)